125 related articles for article (PubMed ID: 9542528)
1. Maintenance of hypomethylation status and preferential expression of exogenous human MDR1/PGY1 gene in mouse L cells by YAC mediated transfer.
Kusaba H; Nakayama M; Harada T; Torigoe K; Green ED; Scherer SW; Kohno K; Kuwano M; Wada M
Somat Cell Mol Genet; 1997 Jul; 23(4):259-74. PubMed ID: 9542528
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells.
Kusaba H; Kohno K; Asakuno K; Kuwano M; Okumura K; Green ED; Schlessinger D; Wada M
Genome Res; 1995 Oct; 5(3):245-58. PubMed ID: 8593612
[TBL] [Abstract][Full Text] [Related]
3. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
[TBL] [Abstract][Full Text] [Related]
4. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
5. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
7. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis P; El-Osta A; deSilva M; Wall DM; Hu XF; Slater A; Nadalin G; Parkin JD; Zalcberg JR
Clin Cancer Res; 1997 Nov; 3(11):2025-32. PubMed ID: 9815593
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.
Nakayama M; Wada M; Harada T; Nagayama J; Kusaba H; Ohshima K; Kozuru M; Komatsu H; Ueda R; Kuwano M
Blood; 1998 Dec; 92(11):4296-307. PubMed ID: 9834236
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of MDR1 gene in breast cancer: CpG methylation status dominates the stable maintenance of a silent gene.
Sharma D; Vertino PM
Cancer Biol Ther; 2004 Jun; 3(6):549-50. PubMed ID: 15254426
[No Abstract] [Full Text] [Related]
10. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
[TBL] [Abstract][Full Text] [Related]
11. Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1.
Suzuki M; Sugimoto Y; Tsuruo T
Mutat Res; 1998 Jun; 401(1-2):133-41. PubMed ID: 9639692
[TBL] [Abstract][Full Text] [Related]
12. The involvement of a LINE-1 element in a DNA rearrangement upstream of the mdr1a gene in a taxol multidrug-resistant murine cell line.
Cohen D; Higman SM; Hsu SI; Horwitz SB
J Biol Chem; 1992 Oct; 267(28):20248-54. PubMed ID: 1356977
[TBL] [Abstract][Full Text] [Related]
13. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.
Hsu SI; Cohen D; Kirschner LS; Lothstein L; Hartstein M; Horwitz SB
Mol Cell Biol; 1990 Jul; 10(7):3596-606. PubMed ID: 1972547
[TBL] [Abstract][Full Text] [Related]
15. Retroviral transfer of human MDR1 gene into human T lymphocytes.
Lee CG; Pastan I; Gottesman MM
Methods Enzymol; 1998; 292():557-72. PubMed ID: 9711583
[No Abstract] [Full Text] [Related]
16. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.
Ogretmen B; Safa AR
Biochemistry; 2000 Jan; 39(1):194-204. PubMed ID: 10625494
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
19. Cloning, transfer, and characterization of multidrug resistance protein.
Grant CE; Bhardwaj G; Cole SP; Deeley RG
Methods Enzymol; 1998; 292():594-607. PubMed ID: 9711585
[No Abstract] [Full Text] [Related]
20. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells.
Kohno K; Tanimura H; Sato S; Nakayama Y; Makino Y; Wada M; Fojo AT; Kuwano M
J Biol Chem; 1994 Aug; 269(32):20503-8. PubMed ID: 7914196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
